Human studies with microneedles for evaluation of their efficacy and safety

References

• Chong RHE, Gonzalez-Gonzalez E, Lara MF, et al. Gene silencing following siRNA delivery to skin via coated steel microneedles: in vitro and in vivo proof-of-concept. J Control Release. 2013;166(3):211–219.
   Web of Science ®Google Scholar
• Choi CK, Kim JB, Jang EH, et al. Curved biodegradable microneedles for vascular drug delivery. Small. 2012;8(16):2483–2488.
   Web of Science ®Google Scholar
• Birchall JC, Coulman SA, Pearton M, et al. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch microfabricated microneedles. J Drug Target. 2005;13(7):415–421.
   PubMed Web of Science ®Google Scholar
• McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Nat Acad Sci USA. 2003;100:13755–13760.
   PubMed Web of Science ®Google Scholar
• Kim YC, Kim SD, Ks K. A case of idiopathic central serous chorioretinopathy in a 12 -year-old male treated with bevacizuma.b. Korean. J Ophthalmol. 2012b;26:391–393.
   Google Scholar
• Mr P. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56:581–587.
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Mr P. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–1568.
   PubMed Web of Science ®Google Scholar
• Gupta J, Gill HS, Andrews SN, et al. Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release. 2011;154:148–155.
   PubMed Web of Science ®Google Scholar
• Muller DA, Pearson FE, Fernando GJP, et al. Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responsed. Sci Rep. 2016;6:1–6.
   PubMed Web of Science ®Google Scholar
• Gill HS, Mr P. Coated microneedles for transdermal delivery. J Control Release. 2007;117:227–237.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TR, Alkilani AZ, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm. 2013;451(1–2):76–91.
   PubMed Web of Science ®Google Scholar
• Larrañeta E, Lutton REM, Brady AJ, et al. Microwave-assisted preparation of hydrogel-forming microneedles arrays for transdermal drug delivery applications. Macromol Mater Eng. 2015;300(6):586–595.
   PubMed Web of Science ®Google Scholar
• Kaushik S, Hord AH, Denson DD, et al. Lack of pain associated with microfabricated microneedles. Anesth Analog. 2001;92:502–504.
   PubMed Web of Science ®Google Scholar
• Quinn HL, Kearney MC, Courtenary AJ, et al. The role of microneedles for drug and vaccine delivery. Exper Opin Drug Deliv. 2014;11(11):1769–1780.
   PubMed Web of Science ®Google Scholar
• Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Pnas. 2008;105(6):2058–2063. DOI:10.1073/pnas0710355105.
   PubMed Web of Science ®Google Scholar
• Bal SM, Kruithof AC, Zwier R, et al. Influence of microneedle shape on the transport of fluorescent dye into human skin in vivo. J Control Release. 2010;147:218–224.
   PubMed Web of Science ®Google Scholar
• Coulman SA, Birchall JC, Alex A, et al. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharm Res. 2011;28:66–81.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Hagino K. Evaluation of the effect of polymeric microneedle arrays of varying geometries in combination with a high-velocity applicator on skin permeability and irritation. Biomed Microdevices. 2014;16:591–597.
   PubMed Web of Science ®Google Scholar
• Enfield J, O’connell ML, Lawlor K, et al. In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. J Biomed Opt. 2010;15(4):046001.
   PubMed Web of Science ®Google Scholar
• Menon GK, Feingold KR, Pm E. Lamellar body secrectory response to barrier disruption. J Invest Dermatol. 1992;98(3):279–289.
   PubMed Web of Science ®Google Scholar
• Bal SM, Kruithof AC, Liebl H, et al. In vivo visualization of microneedle conduits in human skin using laser scanning microscopy. Laser Phys Lett. 2010;7(3):242–246.
   Web of Science ®Google Scholar
• Haq MI, Smith E, John DN, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices. 2009;11:35–47.
   PubMed Web of Science ®Google Scholar
• Kelchen MN, Siefers KJ, Converse CC, et al. Micropore closure kinetics are delayed following microneedle insertion in elderly subjects. J Control Release. 2016;225:294–300.
   PubMed Web of Science ®Google Scholar
• Kelchen MN, Holdren GO, Farley MJ, et al. Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population. Pharm Res. 2014;31(12):3478–3486.
   PubMed Web of Science ®Google Scholar
• Brogden NK, Banks SL, Crofford LJ, et al. Diclofenac enables unprecedented week-long microneedleenhanced delivery of a skin impermeable medication in humans. Pharm Res. 2013;30(8):1947–1955.
   PubMed Web of Science ®Google Scholar
• Brogden NK, Milewski M, Ghosh P, et al. Diclofenac delays micropore closure following microneedle treatment in human subjects. J Control Release. 2012;163(2):220–229.
   PubMed Web of Science ®Google Scholar
• Roxhed N, Gasse TC, Griss P, et al. Penetration-enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery. J Microelectromech Syst. 2007;16(6):1429–1440.
   Web of Science ®Google Scholar
• O'Mahony C. Structural characterization and in-vivo reliablity evaluation of silicon microneedles. Biomed Microdevices. 2014;16(3):333–343.
   PubMed Web of Science ®Google Scholar
• Norman JJ, Arya JM, McClain MA, et al. Microneedle patches: usability and acceptability for self vaccination against influenza. Vaccine. 2014;32(16):1856–1862.
   PubMed Web of Science ®Google Scholar
• Gill HS, Denson DD, Burris BA, et al. Effect of microneedle design on pain in human subjects. Clin J Pain. 2008;24(7):585–594.
   PubMed Web of Science ®Google Scholar
• Noh YW, Kim TH, Baek JS, et al. In vitro characterization of the invasiveness of polymer microneedle against skin. Int J Pharm. 2010;397:201–205.
   PubMed Web of Science ®Google Scholar
• Miyano T, Tobinaga Y, Kanno T, et al. Sugar microneedles as transdermic drug delivery system. Biomed Microdevices. 2005;7(3):185–188.
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Matsuo K, et al. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device. Pharm Res. 2013;30:2664–2674.
   PubMed Web of Science ®Google Scholar
• Ripolin A, Quinn J, Larraneta E, et al. Successful application of large microneedle patches by human voulunteers. Int J Pharm. 2017;521:91–101.
   Google Scholar
• Arya J, Henry S, Kalluri H, et al. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1–7.
   PubMed Web of Science ®Google Scholar
• Rouphael NG, Paine M, Mosley R, et al. The safety, immunogenicity, and acceptability of inactivated ifluenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. The Lancet. 2017;390(10095):649–658.
   PubMed Web of Science ®Google Scholar
• Hiraishi Y, Hirobe S, Iioka H, et al. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans. J Control Release. 2013;171:93–103.
   PubMed Web of Science ®Google Scholar
• Hirobe S, Otsuka R, Iioka H, et al. Clinical study of retionic acid-loaded microneedle patch for seborrheic keratosis or senile lentigo. Life Science. 2016;168:24–27.
   PubMed Web of Science ®Google Scholar
• HIrobe S, Azukizawa H, Hanafusa T, et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials. 2015;57:50–58.
   PubMed Web of Science ®Google Scholar
• Daddona PE, Matriano JA, Mandema J, et al. Parathyroid Hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res. 2011;28:159–165.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Garland MJ, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22:4879–4890.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Mooney K, McCr MTC, et al. Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected. J Pharm Sci. 2014;103:1478–1486.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao R, Qin Z, et al. Microneedle pretreatment improves efficacy of cutaneous topical anesthesia. Am J Emerg Med. 2010;28:130–134.
   PubMed Web of Science ®Google Scholar
• Ornelas J, Foolad N, Shi V, et al. Effect of microneedle pretreatment on topical anesthesia: a randomized clinical trial. JAMA Dermatologycom. 2016. Published online E 1-2. DOI:10.1001/jamadermatol.2015.5544.
   PubMed Web of Science ®Google Scholar
• Fernando GJP, Chen X, Primiero CA, et al. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release. 2012;159(2):215–221.
   PubMed Web of Science ®Google Scholar
• Corbett HJ, Fernando GJP, Chen X, et al. Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. PLOS One. 2010;5:e13460.
   PubMed Web of Science ®Google Scholar
• Salvador EC, Brady AJ, Eltayib E, et al. Hydrogel-forming microneedle arrays allow detection of drugs and glucose in vivo: potential for use in diagnosis and therapeutic drug monitoring. PLOS One. 2015;10(12):1–21.
   Web of Science ®Google Scholar
• Wilson-Welder JH, Torres MP, Kipper MJ, et al. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci. 2009;98:1278–1316.
   PubMed Web of Science ®Google Scholar
• Vogt A, Combadiere B, Hadam S, et al. 40nm, but not 750 or 1,500 m, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126:1316–1322.
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, Kersten Gideon FA, et al. Microneedle-based transcutaneous immunisation in mice with N-Trimethyl Chitosan adjuvanted diphtheria toxoid formulations. Pharm Res. 2010;27:1837–1847.
   PubMed Web of Science ®Google Scholar
• Zaric M, Lyubomska O, Touzelet O, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano. 2013;7(3):2042–2055.
   PubMed Web of Science ®Google Scholar
• Siddhapura K, Harde H SJ. Immunostimulatory effect of tetanus toxoid loaded chitosan nanoparticles following microneedles assisted immunization. Nanomedicine: NBM. 2015;2015:1–10.
   Google Scholar
• Du G, Hathout RM, Nasr M, et al. Intradermal vaccination with hollow microneedles: a comparative study of various protein antigen and adjuvant encapsulated nanoparticles. J Control Release. 2017;266:109–118.
   PubMed Web of Science ®Google Scholar
• Marit de Groot A, Du G, Mönkäre J, et al. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium. J Control Release. 2017;266:27–35.
   PubMed Web of Science ®Google Scholar
• Wing D, Prausnitz MR, Mj B. Skin pretreatment with microneedles prior to pilocarpine iontophoresis increases sweat production. Clin Physial Funct Imaging. 2013;33(6):436–440.
   PubMed Web of Science ®Google Scholar
• Shirkhanzadeh M. Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose. J Mat Sci. 2005;16:37–45.
   Google Scholar
• Donnelly RF, Moffatt K, Alkilani AZ, et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharm Res. 2014;31(8):1989–1999.
   Web of Science ®Google Scholar
• Vicente-Pérez EM, Quinn HL, McAllister E, et al. The use of pressure indicating sensor film to provide feedback upon hydrogel-forming microneedle array self-application In Vivo. Pharm Res. 2016;33:3072–3080.
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bonnet S, Alchas P, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine. 2007;25:8833–8842.
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, Looze FD, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008;198:650–658.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Intanza FW. ® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother. 2013;9:115–121.
   PubMed Web of Science ®Google Scholar
• Van Mulder TJS, Verwulgen S, Beyers KCL, et al. Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects. Hum Vaccin Immunother. 2014;10(12):3746–3753.
   PubMed Web of Science ®Google Scholar
• Gupta J, Felner EI, Mr P. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther. 2011;13(4):451–456.
   PubMed Web of Science ®Google Scholar
• Rini CJ, McVey E, Sutter D, et al. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear. Drug Deliv and Transl Res. 2015;5:332–345.
   PubMed Web of Science ®Google Scholar
• Verbaan FJ, Bal SM, Van Den Berg DJ, et al. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J Control Release. 2006;117:238–245.
   PubMed Web of Science ®Google Scholar
• Coleman BL, McGeer AJ, Halperin SA, et al. A randomized control trial comparing immnuogenicity, safety, and preference for self-versus nurse-administered intradermal influenza vaccine. Vaccine. 2012;30(44):6287–6293.
   Web of Science ®Google Scholar
• Reygrobellet C, Viala-Danten M, Meunier J, et al. Perception and acceptance of intradermal influenza vaccination: patients reported outcomes from phase 3 clinical trials. Human Vaccines. 2010;6(4):336–345.
   PubMed Web of Science ®Google Scholar
• Eizenberg P, Booy R, Naser N, et al. Acceptance of Intanza 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther. 2011;28(8):640–649.
   PubMed Web of Science ®Google Scholar
• Prymula R, Usluer G, Altinel S, et al. Acceptance and opinions of intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey. Adv Ther. 2012;29(1):41–52.
   PubMed Web of Science ®Google Scholar
• Meijer WJ, Wensing AMJ, Bos AA, et al. Influenza vaccination in healthcare workers: comparision of side effects and preferred route of administration of intradermal verus intramuscular administration. Vaccine. 2017;35:1517–1523.
   PubMed Web of Science ®Google Scholar
• Birchall JC, Clemo R, Anstey A, et al. Microneedles in clinical practice-An exploratory study into the opinions of healthcare professionals and public. Pharm Res. 2011;28:95–106.
   PubMed Web of Science ®Google Scholar
• FrenckJr RW, Belshe R, Brady RC, et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone ®) administered by intradermal and intramuscular routeinhealthyadults. Vaccine. 2011;29:5666–5674.
   PubMed Web of Science ®Google Scholar
• Kochba E, Levin Y, Raz I, et al. Improved insulin pharmacokinetics using a novel microneedle device for intradermal delivery in patients with type 2 diabetes. Diabetes Technol Ther. 2016;18(9):1–7.
   PubMed Web of Science ®Google Scholar
• Arnou R, Eavis P, Pardo JRDJ, et al. Immunogenicity, large scale safety and lot conistency of an intradermal influenza vaccine in adults aged 18-60 years. Human Vaccines. 2010;6(4):346–354.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine. 2008;26:6614–6619.
   PubMed Web of Science ®Google Scholar
• Gupta J, Felner EI, Mr P. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther. 2009;11(6):329–337.
   PubMed Web of Science ®Google Scholar
• Thakur RRS, Tekko IA, Al-Shammari F, et al. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery. Drug Deliv and Transl Res. 2016;6(6):800–815.
   PubMed Web of Science ®Google Scholar
• Esposito S, Daleno C, Picciolli I, et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine. 2011;29:7606–7610.
   PubMed Web of Science ®Google Scholar
• Norman JJ, Brown MR, Raviele NA, et al. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2013;14:459–465.
   PubMed Web of Science ®Google Scholar